TrialPediatric blood & cancer2009

A phase II study of Campath-1H in children with relapsed or refractory acute lymphoblastic leukemia: a Children's Oncology Group report.

Anne L Angiolillo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.